Elder Pharma has bought 20-per cent stake in UK-based Neutra Health, a marketing and distribution company listed on Londons Alternative Investment Market (AIM), for Rs47 crore. (See: Elder Pharma to acquire 20-per cent stake in UKs Neutra Health) Alok Saxena, director, international, Elder Pharma, told CNBC-TV 18 in an exclusive interview, shared by the channel with domain-b, that it would not be making an open offer, but plans to take warrants and make the investment directly. He sees the acquisition as an entry point into the regulated market. Confirm for us this particular news - is it 20-per cent stake and how much have you paid for it? Has the payment already been made? Yes, we have put in an offer to buy 20 per cent in Neutra Health Plc, which is a company listed on the AIM stock exchange. For the 20 per cent we will be putting in Rs47 crore but the payment has not been made. It is subject to clearance from the EGM, which will take about 21 days from now. But they have accepted our offer and we hope everything will go forward as planned. What do you stand to gain out of this? Neutra Health is one of the large companies in the UK specialising in nutraceutical products and this is one of the main areas where Elder is quite strong. We are amongst the top three companies in India in the nutraceutical market. So, this will be a very strategic thing for both of us because we could backend our products and their products together could be marketed in the Indian market and our products could be marketed by them in the UK market. This would be an entry point for us into the regulated markets. Sourcehttp://www.domainb.com/companies/companies

<< Back